Insulin lispro is contraindicated in patients experiencing hypoglycemia and those who are sensitive to insulin lispro or one of the inactive substances utilized to create the drug.

Insulin lispro is a pregnancy categoryÂ B drug, meaning animal reproduction studies have not shown risk to the fetus. Nevertheless, there are no well-controlled studies on pregnant women. Per the FDA, this drug should only be used during pregnancy when clearly indicated.

Insulin lispro is not contraindicated in nursing mothers; however, nursing mothers on insulin lispro may need a dose adjustment while lactating.